Surviving mesothelioma: What happens next? By James L. Ferraro | Mesothelioma | Last Modified on Apr 03, 2026 Read More
Purdue Pharma faces $13 billion in penalties... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Have current events made the opioid epidemic... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Does asbestos exposure always lead to mesothelioma? By James L. Ferraro | Asbestos Exposure & Claims | Last Modified on Feb 20, 2026 Read More
Mesothelioma treatment research continues to show promise By James L. Ferraro | Mesothelioma | Last Modified on Feb 27, 2026 Read More
Zantac recall issues: Understanding the signs of... By James L. Ferraro | Zantac Recall | Last Modified on Feb 20, 2026 Read More
Zantac recall issues: Knowing the signs of... By James L. Ferraro | Zantac Recall | Last Modified on Feb 20, 2026 Read More
Food and Drug Administration issues Class I... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Zantac use is now linked to breast... By James L. Ferraro | Zantac Recall | Last Modified on Feb 21, 2026 Read More
Food and Drug Administration recalls: The dangers... By James L. Ferraro | Pharmaceutical Litigation | Last Modified on Feb 20, 2026 Read More
Some mesothelioma patients may qualify for this... By James L. Ferraro | Mesothelioma | Last Modified on Feb 20, 2026 Read More
Companies continue to be fined for exposing... By James L. Ferraro | Asbestos Exposure & Claims | Last Modified on Feb 20, 2026 Read More